<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v2.3 20070202//EN" "archivearticle.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article"><front><journal-meta><journal-id journal-id-type="nlm-ta">BMC Infect Dis</journal-id><journal-title>BMC Infectious Diseases</journal-title><issn pub-type="epub">1471-2334</issn><publisher><publisher-name>BioMed Central</publisher-name><publisher-loc>London</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">1471-2334-5-26</article-id><article-id pub-id-type="pmid">15819995</article-id><article-id pub-id-type="doi">10.1186/1471-2334-5-26</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title>Absence of association between angiotensin converting enzyme polymorphism and development of adult respiratory distress syndrome in patients with severe acute respiratory syndrome: a case control study</article-title></title-group><contrib-group><contrib id="A1" equal-contrib="yes" contrib-type="author"><name><surname>Chan</surname><given-names>KC Allen</given-names></name><xref ref-type="aff" rid="I1">1</xref><xref ref-type="aff" rid="I2">2</xref><email>allen@cuhk.edu.hk</email></contrib><contrib id="A2" equal-contrib="yes" contrib-type="author"><name><surname>Tang</surname><given-names>Nelson LS</given-names></name><xref ref-type="aff" rid="I1">1</xref><xref ref-type="aff" rid="I2">2</xref><email>nelsontang@cuhk.edu.hk</email></contrib><contrib id="A3" contrib-type="author"><name><surname>Hui</surname><given-names>David SC</given-names></name><xref ref-type="aff" rid="I1">1</xref><xref ref-type="aff" rid="I3">3</xref><email>b200945@mailserv.cuhk.edu.hk</email></contrib><contrib id="A4" contrib-type="author"><name><surname>Chung</surname><given-names>Grace TY</given-names></name><xref ref-type="aff" rid="I1">1</xref><xref ref-type="aff" rid="I2">2</xref><email>gracechung@cuhk.edu.hk</email></contrib><contrib id="A5" contrib-type="author"><name><surname>Wu</surname><given-names>Alan KL</given-names></name><xref ref-type="aff" rid="I1">1</xref><xref ref-type="aff" rid="I3">3</xref><email>alanklwu@yahoo.com</email></contrib><contrib id="A6" contrib-type="author"><name><surname>Chim</surname><given-names>Stephen SC</given-names></name><xref ref-type="aff" rid="I1">1</xref><xref ref-type="aff" rid="I2">2</xref><email>sschim@cuhk.edu.hk</email></contrib><contrib id="A7" contrib-type="author"><name><surname>Chiu</surname><given-names>Rossa WK</given-names></name><xref ref-type="aff" rid="I1">1</xref><xref ref-type="aff" rid="I2">2</xref><email>rossachiu@cuhk.edu.hk</email></contrib><contrib id="A8" contrib-type="author"><name><surname>Lee</surname><given-names>Nelson</given-names></name><xref ref-type="aff" rid="I1">1</xref><xref ref-type="aff" rid="I3">3</xref><email>leelsn@yahoo.com</email></contrib><contrib id="A9" contrib-type="author"><name><surname>Choi</surname><given-names>KW</given-names></name><xref ref-type="aff" rid="I1">1</xref><xref ref-type="aff" rid="I3">3</xref><email>kwchoi12@netvigator.com</email></contrib><contrib id="A10" contrib-type="author"><name><surname>Sung</surname><given-names>YM</given-names></name><xref ref-type="aff" rid="I2">2</xref><email>mandysung@cuhk.edu.hk</email></contrib><contrib id="A11" contrib-type="author"><name><surname>Chan</surname><given-names>Paul KS</given-names></name><xref ref-type="aff" rid="I1">1</xref><xref ref-type="aff" rid="I4">4</xref><email>paulkschan@cuhk.edu.hk</email></contrib><contrib id="A12" contrib-type="author"><name><surname>Tong</surname><given-names>YK</given-names></name><xref ref-type="aff" rid="I1">1</xref><xref ref-type="aff" rid="I2">2</xref><email>yktong@cuhk.edu.hk</email></contrib><contrib id="A13" contrib-type="author"><name><surname>Lai</surname><given-names>ST</given-names></name><xref ref-type="aff" rid="I5">5</xref><email>laist@ha.org.hk</email></contrib><contrib id="A14" contrib-type="author"><name><surname>Yu</surname><given-names>WC</given-names></name><xref ref-type="aff" rid="I5">5</xref><email>yuwc@ha.org.hk</email></contrib><contrib id="A15" contrib-type="author"><name><surname>Tsang</surname><given-names>Owen</given-names></name><xref ref-type="aff" rid="I5">5</xref><email>tyotsang@hotmail.com</email></contrib><contrib id="A16" corresp="yes" contrib-type="author"><name><surname>Lo</surname><given-names>YM Dennis</given-names></name><xref ref-type="aff" rid="I1">1</xref><xref ref-type="aff" rid="I2">2</xref><email>loym@cuhk.edu.hk</email></contrib></contrib-group><aff id="I1"><label>1</label>The Centre for Emerging Infectious Diseases, The Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong</aff><aff id="I2"><label>2</label>Department of Chemical Pathology, The Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong</aff><aff id="I3"><label>3</label>Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong</aff><aff id="I4"><label>4</label>Department of Microbiology, The Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong</aff><aff id="I5"><label>5</label>Department of Medicine and Geriatrics, Princess Margaret Hospital, Hong Kong</aff><pub-date pub-type="collection"><year>2005</year></pub-date><pub-date pub-type="epub"><day>9</day><month>4</month><year>2005</year></pub-date><volume>5</volume><fpage>26</fpage><lpage>26</lpage><ext-link ext-link-type="uri" xlink:href="http://www.biomedcentral.com/1471-2334/5/26"/><history><date date-type="received"><day>11</day><month>1</month><year>2005</year></date><date date-type="accepted"><day>9</day><month>4</month><year>2005</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2005 Chan et al; licensee BioMed Central Ltd.</copyright-statement><copyright-year>2005</copyright-year><copyright-holder>Chan et al; licensee BioMed Central Ltd.</copyright-holder><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/2.0"><p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/2.0"/>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</p><!--<rdf xmlns="http://web.resource.org/cc/" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dc="http://purl.org/dc/elements/1.1" xmlns:dcterms="http://purl.org/dc/terms"><Work xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" rdf:about=""><license rdf:resource="http://creativecommons.org/licenses/by/2.0"/><dc:type rdf:resource="http://purl.org/dc/dcmitype/Text"/><dc:author> Chan KC Allen allen@cuhk.edu.hk </dc:author><dc:title> Absence of association between angiotensin converting enzyme polymorphism and development of adult respiratory distress syndrome in patients with severe acute respiratory syndrome: a case control study </dc:title><dc:date>2005</dc:date><dcterms:bibliographicCitation>BMC Infectious Diseases 5(1): 26-. (2005)</dcterms:bibliographicCitation><dc:identifier type="sici">1471-2334(2005)5:1&#x0003c;26&#x0003e;</dc:identifier><dcterms:isPartOf>urn:ISSN:1471-2334</dcterms:isPartOf><License rdf:about="http://creativecommons.org/licenses/by/2.0"><permits rdf:resource="http://web.resource.org/cc/Reproduction" xmlns=""/><permits rdf:resource="http://web.resource.org/cc/Distribution" xmlns=""/><requires rdf:resource="http://web.resource.org/cc/Notice" xmlns=""/><requires rdf:resource="http://web.resource.org/cc/Attribution" xmlns=""/><permits rdf:resource="http://web.resource.org/cc/DerivativeWorks" xmlns=""/></License></Work></rdf>--></license></permissions><abstract><sec><title>Background</title><p>It has been postulated that genetic predisposition may influence the susceptibility to SARS-coronavirus infection and disease outcomes. A recent study has suggested that the deletion allele (D allele) of the <italic>angiotensin converting enzyme </italic>(<italic>ACE</italic>) gene is associated with hypoxemia in SARS patients. Moreover, the <italic>ACE </italic>D allele has been shown to be more prevalent in patients suffering from adult respiratory distress syndrome (ARDS) in a previous study. Thus, we have investigated the association between ACE insertion/deletion (I/D) polymorphism and the progression to ARDS or requirement of intensive care in SARS patients.</p></sec><sec sec-type="methods"><title>Method</title><p>One hundred and forty genetically unrelated Chinese SARS patients and 326 healthy volunteers were recruited. The ACE I/D genotypes were determined by polymerase chain reaction and agarose gel electrophoresis.</p></sec><sec><title>Results</title><p>There is no significant difference in the genotypic distributions and the allelic frequencies of the ACE I/D polymorphism between the SARS patients and the healthy control subjects. Moreover, there is also no evidence that ACE I/D polymorphism is associated with the progression to ARDS or the requirement of intensive care in the SARS patients. In multivariate logistic analysis, age is the only factor associated with the development of ARDS while age and male sex are independent factors associated with the requirement of intensive care.</p></sec><sec><title>Conclusion</title><p>The ACE I/D polymorphism is not directly related to increased susceptibility to SARS-coronavirus infection and is not associated with poor outcomes after SARS-coronavirus infection.</p></sec></abstract></article-meta></front><body><sec><title>Background</title><p>The outbreak of the severe acute respiratory syndrome (SARS) has made a great impact to the health care systems around the world. The pandemic affected over 8000 individuals and resulted in 774 deaths worldwide [<xref ref-type="bibr" rid="B1">1</xref>]. Several clinical parameters, including male sex [<xref ref-type="bibr" rid="B2">2</xref>,<xref ref-type="bibr" rid="B3">3</xref>], age of over 60 years [<xref ref-type="bibr" rid="B2">2</xref>,<xref ref-type="bibr" rid="B3">3</xref>], elevated lactate dehydrogenase activity [<xref ref-type="bibr" rid="B2">2</xref>-<xref ref-type="bibr" rid="B4">4</xref>], low platelet count [<xref ref-type="bibr" rid="B2">2</xref>] and high viral load on presentation [<xref ref-type="bibr" rid="B5">5</xref>], have been identified to be predictive of the severity of the disease in affected individuals. Moreover, it has been postulated that genetic variations of the host and the virus may account for the individual difference in the susceptibility to the infection and the severity of the disease. With regard to viral factors, it has been shown that there is no significant difference in the genetic sequences of viruses causing the two major outbreaks in Hong Kong, namely the Prince of Wales Hospital and Amoy Gardens outbreaks, despite the significant difference in the mortality rates and diarrheal rates of the two cohorts [<xref ref-type="bibr" rid="B6">6</xref>]. Furthermore, several association studies have been conducted to investigate the possible contribution of host genetic factors in the determination of the susceptibility and prognosis of SARS-coronavirus infection. Thus, certain human leukocyte antigen subtypes have been shown to be more prevalent in SARS patients [<xref ref-type="bibr" rid="B7">7</xref>] and in those who had poorer outcomes [<xref ref-type="bibr" rid="B8">8</xref>]. On the other hand, the polymorphism in the angiotensin converting enzyme II gene, coding for a functional receptor of the SARS-coronavirus, is not associated with the susceptibility or outcome of SARS [<xref ref-type="bibr" rid="B9">9</xref>]. Recently, it has also been reported that the deletion of the 287 bp <italic>Alu </italic>repeat (D allele) in intron 16 of the <italic>ACE </italic>gene is associated with hypoxemia in SARS patients [<xref ref-type="bibr" rid="B10">10</xref>]. However, there are several limitations to this previous study. First, only 44 SARS patients were studied. Second, hypoxemia was arbitrarily defined as requiring oxygen supplementation. Moreover, patients who died were excluded from the study. These factors may be potential confounders to a genetic association study.</p><p>Therefore, in this study, we investigated the association of the <italic>ACE </italic>insertion/deletion (I/D) polymorphism of the 287 bp <italic>Alu </italic>repeat to the susceptibility to SARS and the development of adult respiratory distress syndrome (ARDS) with a larger population.</p></sec><sec sec-type="methods"><title>Methods</title><sec><title>Study population</title><p>This study was reviewed and approved by the Ethical Committee of the Prince of Wales Hospital, Hong Kong. Patients who were admitted to the hospitals of the New Territories East cluster of Hong Kong for the treatment of SARS were recruited retrospectively. The recruitment of patients depended on the availability of blood samples. All patients, including survivors and deceased patients, with available blood samples were recruited. For genetically related SARS patients, only the index case (the first individual who developed symptoms) was recruited. All patients were of Chinese ethnicity and fulfilled the World Health Organisation case definition of probable SARS [<xref ref-type="bibr" rid="B11">11</xref>]. Three hundred and twenty-six healthy individuals undergoing routine health check were recruited as controls. The control subjects were recruited before the SARS epidemic and none of them had respiratory symptoms. All control subjects were ethnical Chinese and were not genetically related.</p></sec><sec><title>Definition of adult respiratory distress syndrome (ARDS) and patients with severe disease</title><p>The association between genotype and disease outcome was studied in the SARS patients. Two categories of patients were considered as having a severe disease: (1) patients who developed ARDS; and (2) patients who required admission to the intensive care unit (ICU). A patient was classified as having ARDS if he or she fulfilled all criteria of the joint American/European Consensus for ARDS [<xref ref-type="bibr" rid="B12">12</xref>], including: (1) acute onset of respiratory distress; (2) presence of bilateral infiltrates on chest X-ray; (3) having a ratio of arterial partial pressure of oxygen to inspired fractional oxygen concentration (PaO<sub>2</sub>/FiO<sub>2</sub>) of less than 26.8 kPa and absence of clinical evidence of left heart failure.</p></sec><sec><title>ACE Genotyping</title><p>DNA was extracted from whole blood using a QIAamp DNA Blood Mini Kit (Qiagen) with the 'Blood and Body Fluid Spin protocol' as recommended by the manufacturer. ACE I/D genotypes were determined by polymerase chain reaction amplification. The forward and reverse primers were 5'-CTGGAGACCACTCCCATCCTTTCT-3' and 5'-GATGTGGCCATCACATTCGTCAGAT-3', respectively. Reactions were set up in a volume of 25 &#x003bc;l containing 0.1 &#x003bc;M of each primer, 1X buffer II (Applied Biosystems), 2 mM MgCl<sub>2</sub>, 0.2 mM of each dNTP, 1.25 U Taq polymerase (AmpliTaq Gold DNA polymerase, Applied Biosystems) and 20 ng DNA. After initial denaturation at 95&#x000b0;C for 12 min, the reaction mixtures were subjected to 40 cycles of 94&#x000b0;C for 1 min, 58&#x000b0;C for 1 min and 72&#x000b0;C for 1 min, and a final extension at 72&#x000b0;C for 5 min. This method yielded amplification products of 480 bp for the I allele and 192 bp for the D allele. The products were electrophoresed and visualized in 2% agarose gels with ethidium bromide.</p></sec><sec><title>Statistical analysis</title><p>Statistical analyses were performed using SigmaStat, Ver. 3.0; SPSS. Disease associations were compared by chi-square tests. Univariate and multivariate logistic regression analyses were performed to identify predictors of ARDS or the outcome of SARS.</p></sec></sec><sec><title>Results</title><sec><title>Demographics</title><p>One hundred and forty SARS patients (67 males, 73 females) and 326 healthy individuals (172 males, 154 females) were recruited. The mean ages of the SARS patients and control subjects were 39.9 and 42.5 years, respectively (<italic>p </italic>= 0.93). Seventeen of the 140 SARS patients developed ARDS during the course of their illness. The demographic data of the SARS patients who had or had not developed ARDS are summarized in table <xref ref-type="table" rid="T1">1</xref>. Patients who developed ARDS were significantly older than those who did not develop ARDS (p &#x0003c; 0.001). There was no significant difference in gender, smoking habits, hepatitis B status and the presence of comorbidity between the two groups. Thirty-five patients required intensive care and sixteen died. Patients who required intensive care were significantly older than those with milder disease.</p><table-wrap position="float" id="T1"><label>Table 1</label><caption><p>Demographic data of SARS patients. The patients are categorized by the development of ARDS (ARDS vs non-ARDS). All patients who had developed ARDS required intensive care. The numbers listed in the table represent the number of patients (except the numbers list in the first row which signify age).</p></caption><table frame="hsides" rules="groups"><thead><tr><td></td><td align="center"><bold>ARDS</bold></td><td align="center"><bold>non-ARDS</bold></td></tr></thead><tbody><tr><td align="left">Age mean (range)</td><td align="center">59.1 years (24&#x02013;83)</td><td align="center">36.9 years (21&#x02013;76)</td></tr><tr><td align="left">M:F</td><td align="center">9/8</td><td align="center">58/65</td></tr><tr><td align="left">Smoking</td><td align="center">2</td><td align="center">5</td></tr><tr><td align="left">HbsAg positive</td><td align="center">0</td><td align="center">7</td></tr><tr><td align="left">Comorbidities</td><td></td><td></td></tr><tr><td align="left">&#x02003;&#x02003;chronic obstructive pulmonary disease</td><td align="center">0</td><td align="center">3</td></tr><tr><td align="left">&#x02003;&#x02003;Ischemic heart disease</td><td align="center">5</td><td align="center">2</td></tr><tr><td align="left">&#x02003;&#x02003;Cerebral vascular disease</td><td align="center">3</td><td align="center">4</td></tr><tr><td align="left">&#x02003;&#x02003;Cancer</td><td align="center">0</td><td align="center">2</td></tr><tr><td align="left">&#x02003;&#x02003;Diabetes mellitus</td><td align="center">1</td><td align="center">6</td></tr><tr><td align="left">&#x02003;&#x02003;Chronic renal disease</td><td align="center">0</td><td align="center">1</td></tr><tr><td align="left">&#x02003;&#x02003;Liver cirrhosis</td><td align="center">0</td><td align="center">1</td></tr></tbody></table></table-wrap></sec><sec><title>Genotypic and allelic frequencies of ACE I/D polymorphism</title><p>The genotypic distributions and allelic frequencies of ACE I/D polymorphism in the SARS patients and control subjects are shown in table <xref ref-type="table" rid="T2">2</xref>. The genotypic distributions of the SARS patients and the healthy control subjects follow the Hardy-Weinberg equilibrium using chi-square analysis. There was no significant difference in the genotypic distributions (&#x003c7;<sup>2 </sup>value = 1.43, df = 2, <italic>p </italic>= 0.489) and allelic frequencies (&#x003c7;<sup>2 </sup>value = 0.000624, df = 1, <italic>p </italic>= 0.980) of the two groups. Among the SARS patients, we further analyzed the genotypic distributions and allelic frequencies of ACE I/D polymorphism in patients who developed ARDS and in those who did not develop ARDS in the course of their illness. The results are shown in table <xref ref-type="table" rid="T3">3a</xref>. There was no significant difference in the genotypic distributions (&#x003c7;<sup>2 </sup>value = 4.361, df = 2, <italic>p </italic>= 0.113) and allelic frequencies (&#x003c7;<sup>2 </sup>value = 1.376, df = 1, <italic>p </italic>= 0.241) between the two groups. Besides, there was also no significant difference in the genotypic distributions (&#x003c7;<sup>2 </sup>value = 2.489, df = 2, <italic>p </italic>= 0.288) and allelic frequencies (&#x003c7;<sup>2 </sup>value = 1.424, df = 1, <italic>p </italic>= 0.233) between patients who did or did not require intensive care. The results are shown in table <xref ref-type="table" rid="T4">3b</xref>.</p><table-wrap position="float" id="T2"><label>Table 2</label><caption><p>Genotypic and allelic frequencies of ACE I/D polymorphism in SARS patients and control subjects</p></caption><table frame="hsides" rules="groups"><thead><tr><td></td><td align="center"><bold><italic>SARS cases</italic></bold></td><td align="center"><bold><italic>Controls</italic></bold></td></tr></thead><tbody><tr><td></td><td align="center">n = 140</td><td align="center">n = 326</td></tr><tr><td align="center" colspan="3"><italic>Genotypic frequency</italic></td></tr><tr><td colspan="3"><hr></hr></td></tr><tr><td align="center"><bold><italic>DD</italic></bold></td><td align="center">15 (11%)</td><td align="center">43 (13%)</td></tr><tr><td align="center"><bold><italic>ID</italic></bold></td><td align="center">65 (46%)</td><td align="center">133 (41%)</td></tr><tr><td align="center"><bold><italic>II</italic></bold></td><td align="center">60 (43%)</td><td align="center">150 (46%)</td></tr><tr><td align="center" colspan="3">&#x003c7;<sup>2 </sup>value = 1.43, df = 2, <italic>p </italic>= 0.489</td></tr><tr><td></td><td></td><td></td></tr><tr><td align="center" colspan="3"><italic>Allelic frequency</italic></td></tr><tr><td colspan="3"><hr></hr></td></tr><tr><td align="center"><bold><italic>D</italic></bold></td><td align="center">95 (34%)</td><td align="center">219 (34%)</td></tr><tr><td align="center"><bold><italic>I</italic></bold></td><td align="center">185 (66%)</td><td align="center">433 (66%)</td></tr><tr><td align="center" colspan="3">&#x003c7;<sup>2 </sup>value = 0.000624, df = 1, <italic>p </italic>= 0.980</td></tr></tbody></table></table-wrap><table-wrap position="float" id="T3"><label>Table 3a</label><caption><p>Genotypic and allelic frequencies of ACE I/D polymorphism in SARS patients who had developed or had not developed ARDS</p></caption><table frame="hsides" rules="groups"><thead><tr><td></td><td align="center"><bold><italic>ARDS</italic></bold></td><td align="center"><bold><italic>Non-ARDS</italic></bold></td></tr></thead><tbody><tr><td></td><td align="center">n = 17</td><td align="center">n = 123</td></tr><tr><td align="center" colspan="3"><italic>Genotypic frequency</italic></td></tr><tr><td colspan="3"><hr></hr></td></tr><tr><td align="center"><bold><italic>DD</italic></bold></td><td align="center">2 (12%)</td><td align="center">13 (10%)</td></tr><tr><td align="center"><bold><italic>ID</italic></bold></td><td align="center">4 (23%)</td><td align="center">61 (50%)</td></tr><tr><td align="center"><bold><italic>II</italic></bold></td><td align="center">11 (65%)</td><td align="center">49 (40%)</td></tr><tr><td align="center" colspan="3">&#x003c7;<sup>2 </sup>value = 4.361, df = 2, <italic>p </italic>= 0.113</td></tr><tr><td></td><td></td><td></td></tr><tr><td align="center" colspan="3"><italic>Allelic frequency</italic></td></tr><tr><td colspan="3"><hr></hr></td></tr><tr><td align="center"><bold><italic>D</italic></bold></td><td align="center">8 (24%)</td><td align="center">87 (35%)</td></tr><tr><td align="center"><bold><italic>I</italic></bold></td><td align="center">26 (76%)</td><td align="center">159 (65%)</td></tr><tr><td align="center" colspan="3">&#x003c7;<sup>2 </sup>value = 1.376, df = 1, <italic>p </italic>= 0.241</td></tr></tbody></table></table-wrap><table-wrap position="float" id="T4"><label>Table 3b</label><caption><p>Genotypic and allelic frequencies of ACE I/D polymorphism in SARS patients who had or had not required intensive care (ICU vs non-ICU)</p></caption><table frame="hsides" rules="groups"><thead><tr><td></td><td align="center"><bold><italic>ICU</italic></bold></td><td align="center"><bold><italic>Non-ICU</italic></bold></td></tr></thead><tbody><tr><td></td><td align="center">n = 35</td><td align="center">n = 105</td></tr><tr><td align="center" colspan="3"><italic>Genotypic frequency</italic></td></tr><tr><td colspan="3"><hr></hr></td></tr><tr><td align="center">DD</td><td align="center">3 (9%)</td><td align="center">12 (11%)</td></tr><tr><td align="center">ID</td><td align="center">13 (37%)</td><td align="center">52 (50%)</td></tr><tr><td align="center">II</td><td align="center">19 (54%)</td><td align="center">41 (39%)</td></tr><tr><td align="center" colspan="3">&#x003c7;<sup>2 </sup>value = 2.489, df = 2, <italic>p </italic>= 0.288</td></tr><tr><td></td><td></td><td></td></tr><tr><td align="center" colspan="3"><italic>Allelic frequency</italic></td></tr><tr><td colspan="3"><hr></hr></td></tr><tr><td align="center">D</td><td align="center">19 (27%)</td><td align="center">76 (36%)</td></tr><tr><td align="center">I</td><td align="center">51 (73%)</td><td align="center">134 (64%)</td></tr><tr><td align="center" colspan="3">&#x003c7;<sup>2 </sup>value = 1.424, df = 1, <italic>p </italic>= 0.233</td></tr></tbody></table></table-wrap></sec><sec><title>Logistic regression on the development of ARDS or requirement of intensive care</title><p>In the univariate analysis, we did not detect any significant difference in the number of D alleles in the ACE polymorphism between patients who did and did not develop ARDS (p = 0.169, OR = 0.549 (95% CI: 0.23&#x02013;1.29). Following multivariate logistic regression analysis, age was found to be the only significant factor that determined the development of ARDS in SARS patients (table <xref ref-type="table" rid="T5">4a</xref>). In the multivariate analysis for the requirement of intensive care, we have shown that age and male sex are associated with the requirement of intensive care (table <xref ref-type="table" rid="T6">4b</xref>).</p><table-wrap position="float" id="T5"><label>Table 4a</label><caption><p>Logistic regression on the development of ARDS in SARS patients</p></caption><table frame="hsides" rules="groups"><thead><tr><td align="center"><bold><italic>Variables</italic></bold></td><td align="center" colspan="2"><bold>Univariate analysis</bold></td><td align="center" colspan="2"><bold>Multivariate analysis</bold></td></tr><tr><td></td><td colspan="4"><hr></hr></td></tr><tr><td></td><td align="center"><bold><italic>Odds ratio (95% CI)</italic></bold></td><td align="center"><bold><italic>p value</italic></bold></td><td align="center"><bold><italic>Odds ratio (95% CI)</italic></bold></td><td align="center"><bold><italic>p value</italic></bold></td></tr></thead><tbody><tr><td align="center">ACE (no. of D allele)</td><td align="center">0.64 (0.28 &#x02013; 1.47)</td><td align="center">0.30</td><td align="center">0.74 (0.27 &#x02013; 1.98)</td><td align="center">0.46</td></tr><tr><td align="center">Age</td><td align="center">1.08 (1.04 &#x02013; 1.12)</td><td align="center">&#x0003c;0.01</td><td align="center">1.10 (1.04 &#x02013; 1.16)</td><td align="center">&#x0003c;0.01</td></tr><tr><td align="center">Male sex</td><td align="center">1.26 (0.46 &#x02013; 3.48)</td><td align="center">0.65</td><td align="center">0.22 (0.04 &#x02013; 1.10)</td><td align="center">0.06</td></tr><tr><td align="center">Smoking</td><td align="center">3.15 (0.56 &#x02013; 17.67)</td><td align="center">0.19</td><td align="center">1.03 (0.11 &#x02013; 9.65)</td><td align="center">0.98</td></tr><tr><td align="center">HbsAg</td><td align="center">1 (0 &#x02013; &#x0221e;)</td><td align="center">0.99</td><td align="center">1 (0.00 &#x02013; &#x0221e;)</td><td align="center">0.99</td></tr><tr><td align="center">Co-morbidities</td><td align="center">6.15 (2.11 &#x02013; 17.96)</td><td align="center">&#x0003c;0.01</td><td align="center">1.61 (0.36 &#x02013; 7.26)</td><td align="center">0.53</td></tr></tbody></table></table-wrap><table-wrap position="float" id="T6"><label>Table 4b</label><caption><p>Logistic regression on the requirement of intensive care in SARS patients</p></caption><table frame="hsides" rules="groups"><thead><tr><td align="center"><bold><italic>Variables</italic></bold></td><td align="center" colspan="2"><bold>Univariate analysis</bold></td><td align="center" colspan="2"><bold>Multivariate analysis</bold></td></tr><tr><td></td><td colspan="4"><hr></hr></td></tr><tr><td></td><td align="center"><bold><italic>Odds ratio (95% CI)</italic></bold></td><td align="center"><bold><italic>p value</italic></bold></td><td align="center"><bold><italic>Odds ratio (95% CI)</italic></bold></td><td align="center"><bold><italic>p value</italic></bold></td></tr></thead><tbody><tr><td align="center">ACE (no. of D allele)</td><td align="center">0.69 (0.38 &#x02013; 1.27)</td><td align="center">0.23</td><td align="center">0.77 (0.39 &#x02013; 1.51)</td><td align="center">0.46</td></tr><tr><td align="center">Age</td><td align="center">1.06 (1.03 &#x02013; 1.08)</td><td align="center">&#x0003c;0.01</td><td align="center">1.06 (1.02 &#x02013; 1.09)</td><td align="center">&#x0003c;0.01</td></tr><tr><td align="center">Male sex</td><td align="center">4.50 (1.92 &#x02013; 10.58)</td><td align="center">&#x0003c;0.01</td><td align="center">3.20 (1.25 &#x02013; 8.19)</td><td align="center">0.02</td></tr><tr><td align="center">Smoking</td><td align="center">2.37 (0.50 &#x02013; 11.14)</td><td align="center">0.28</td><td align="center">0.68 (0.10 &#x02013; 4.52)</td><td align="center">0.69</td></tr><tr><td align="center">HbsAg</td><td align="center">2.37 (0.50 &#x02013; 11.14)</td><td align="center">0.28</td><td align="center">2.73 (0.52 &#x02013; 14.43)</td><td align="center">0.24</td></tr><tr><td align="center">Co-morbidities</td><td align="center">6.15 (2.11 &#x02013; 17.96)</td><td align="center">&#x0003c;0.01</td><td align="center">1.61 (0.36 &#x02013; 7.26)</td><td align="center">0.53</td></tr></tbody></table></table-wrap></sec></sec><sec><title>Discussion</title><p>The possible contribution of host genetic factors to the susceptibility and outcome of SARS-coronavirus infection has been investigated through several association studies [<xref ref-type="bibr" rid="B7">7</xref>-<xref ref-type="bibr" rid="B10">10</xref>]. In contrast to a recent report showing an association between the presence of the D allele of the <italic>ACE </italic>gene and hypoxemia in SARS patients [<xref ref-type="bibr" rid="B10">10</xref>], we have shown that the I/D polymorphism of the <italic>ACE </italic>gene is associated with neither increased susceptibility to SARS-coronavirus infection nor progression to ARDS once infected. In multivariate logistic regression analysis, we have identified that age is the only significant factor associated with the development of ARDS while age and male sex are independently associated with the requirement of intensive care in SARS patients. Our findings are consistent with other published reports [<xref ref-type="bibr" rid="B2">2</xref>,<xref ref-type="bibr" rid="B3">3</xref>].</p><p>There are several possible explanations for the discrepancies in our conclusion and that by Itoyama et al [<xref ref-type="bibr" rid="B10">10</xref>] concerning the association between <italic>ACE </italic>polymorphism and the outcome of SARS. First, the inclusion of subjects within the same family and exclusion of deceased patients by the previous study might cause potential bias, especially when the frequency of the DD genotype was reported to be as low as 6% in control subjects [<xref ref-type="bibr" rid="B10">10</xref>]. In this study, we have only included the index patient if more than one member in a family developed SARS. Second, we have used a well defined endpoint of ARDS instead of the requirement of supplemental oxygen. SARS infection commonly leads to respiratory distress and over 80% of patients were given supplemental oxygen during the course of their illness in our cohort. Therefore, it seems to be more appropriate to use ARDS instead of the requirement of oxygen supplement to define the severity of SARS. As ARDS is the more severe end of the spectrum of disease progression, any potential association between genotype and disease progression would become even more obvious when the most severe cases were considered. Similarly, the disease outcome was not associated with ACE I/D genotype when we also used another broader definition for severe disease after SARS infection (requiring intensive care or death).</p><p>Previous studies on Caucasian populations have suggested that the presence of the D allele of the <italic>ACE </italic>gene is associated with increased incidence of ARDS [<xref ref-type="bibr" rid="B13">13</xref>]. This effect has been postulated to be related to the higher enzyme activity in individuals with DD genotype [<xref ref-type="bibr" rid="B15">15</xref>]. However, it is unclear whether these observations can also be seen in Chinese as the frequencies of DD genotype and D allele of the <italic>ACE </italic>gene are much lower in Chinese than in Caucasian subjects [<xref ref-type="bibr" rid="B13">13</xref>,<xref ref-type="bibr" rid="B16">16</xref>]. Furthermore, the SARS-coronavirus characteristically affects the pneumocytes, and the formation of multinucleated pneumocytes and intrabronchial fibrogranulation (bronchiolitis obliterans organizing pneumonia-like lesions) are commonly observed in the lung biopsies of SARS patients in addition to the typical pathological changes of ARDS [<xref ref-type="bibr" rid="B17">17</xref>]. Therefore, it is possible that the pathogenesis and genetic factors predisposing to SARS-related ARDS may be different from ARDS resulted from other respiratory illnesses.</p><p>Previous reports have highlighted the inconsistency of the results of genetic association studies for complex diseases [<xref ref-type="bibr" rid="B18">18</xref>,<xref ref-type="bibr" rid="B19">19</xref>]. This inconsistency may be attributable to the difference in the genetic composition of the studied population and study design. Here, we showed that both susceptibility and disease outcome of SARS infection were not associated with ACE I/D polymorphism among Chinese patients in contrast to the recent report studying Vietnamese patients [<xref ref-type="bibr" rid="B10">10</xref>]. The sample size was definitively larger in our study. Two different better-defined criteria were used as indicators of severe disease progression, yet no association was found between disease severity and ACE I/D genotype. The D allele which was the hypothetical high risk allele [<xref ref-type="bibr" rid="B13">13</xref>], did not show any sign of over-representation in the subgroups of patients with severe disease.</p></sec><sec><title>Conclusion</title><p>Our analysis indicates that ACE I/D polymorphism is not directly related to poor outcomes after SARS-coronavirus infection in Chinese.</p></sec><sec><title>List of abbreviations used</title><p>ACE: angiotensin converting enzyme</p><p>SARS: severe acute respiratory syndrome</p><p>ARDS: adult respiratory distress syndrome</p><p>ACE I/D polymorphism: angiotensin converting enzyme insertion/deletion polymorphism</p></sec><sec><title>Competing interests</title><p>YMDL, KCAC, RWKC, SCCC and YKT have filed patent applications on aspects concerning the genomics and detection of the SARS-coronavirus.</p></sec><sec><title>Authors' contributions</title><p>KCAC, NLST, GTYC, and YMDL have contributed in the preparation of the manuscript and the overall study design. RWKC, SSCC, YKT, PKSC and YMS have contributed in the data analysis and conducting the experiments. DSCH, AKLW, NL, KWC, PKSC, STL, WCY and OT have contributed in the collection and analysis of clinical data from the patients.</p></sec><sec><title>Pre-publication history</title><p>The pre-publication history for this paper can be accessed here:</p><p><ext-link ext-link-type="uri" xlink:href="http://www.biomedcentral.com/1471-2334/5/26/prepub"/></p></sec></body><back><ack><sec><title>Acknowledgements</title><p>The work is supported by the Research Fund for the Control of Infectious Disease (RFCID) from the Health, Welfare and Food Bureau of the Hong Kong SAR Government. We thank Coral Lee, WB Lui and Katherine Chow for technical support.</p></sec></ack><ref-list><ref id="B1"><citation citation-type="other"><person-group person-group-type="author"><collab>WHO</collab></person-group><article-title>Cumulative number of reported probable cases of SARS</article-title><source>http://wwwwhoint/csr/sars/country/2003_07)11/en/</source><year>2004</year></citation></ref><ref id="B2"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tsui</surname><given-names>PT</given-names></name><name><surname>Kwok</surname><given-names>ML</given-names></name><name><surname>Yuen</surname><given-names>H</given-names></name><name><surname>Lai</surname><given-names>ST</given-names></name></person-group><article-title>Severe acute respiratory syndrome: clinical outcome and prognostic correlates</article-title><source>Emerg Infect Dis</source><year>2003</year><volume>9</volume><fpage>1064</fpage><lpage>1069</lpage><pub-id pub-id-type="pmid">14519241</pub-id></citation></ref><ref id="B3"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Leung</surname><given-names>GM</given-names></name><name><surname>Hedley</surname><given-names>AJ</given-names></name><name><surname>Ho</surname><given-names>LM</given-names></name><name><surname>Chau</surname><given-names>P</given-names></name><name><surname>Wong</surname><given-names>IO</given-names></name><name><surname>Thach</surname><given-names>TQ</given-names></name><name><surname>Ghani</surname><given-names>AC</given-names></name><name><surname>Donnelly</surname><given-names>CA</given-names></name><name><surname>Fraser</surname><given-names>C</given-names></name><name><surname>Riley</surname><given-names>S</given-names></name><name><surname>Ferguson</surname><given-names>NM</given-names></name><name><surname>Anderson</surname><given-names>RM</given-names></name><name><surname>Tsang</surname><given-names>T</given-names></name><name><surname>Leung</surname><given-names>PY</given-names></name><name><surname>Wong</surname><given-names>V</given-names></name><name><surname>Chan</surname><given-names>JC</given-names></name><name><surname>Tsui</surname><given-names>E</given-names></name><name><surname>Lo</surname><given-names>SV</given-names></name><name><surname>Lam</surname><given-names>TH</given-names></name></person-group><article-title>The epidemiology of severe acute respiratory syndrome in the 2003 Hong Kong epidemic: an analysis of all 1755 patients</article-title><source>Ann Intern Med</source><year>2004</year><volume>141</volume><fpage>662</fpage><lpage>673</lpage><pub-id pub-id-type="pmid">15520422</pub-id></citation></ref><ref id="B4"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chan</surname><given-names>MH</given-names></name><name><surname>Wong</surname><given-names>VW</given-names></name><name><surname>Wong</surname><given-names>CK</given-names></name><name><surname>Chan</surname><given-names>PK</given-names></name><name><surname>Chu</surname><given-names>CM</given-names></name><name><surname>Hui</surname><given-names>DS</given-names></name><name><surname>Suen</surname><given-names>MW</given-names></name><name><surname>Sung</surname><given-names>JJ</given-names></name><name><surname>Chung</surname><given-names>SS</given-names></name><name><surname>Lam</surname><given-names>CW</given-names></name></person-group><article-title>Serum LD1 isoenzyme and blood lymphocyte subsets as prognostic indicators for severe acute respiratory syndrome</article-title><source>J Intern Med</source><year>2004</year><volume>255</volume><fpage>512</fpage><lpage>518</lpage><pub-id pub-id-type="pmid">15049886</pub-id><pub-id pub-id-type="doi">10.1111/j.1365-2796.2004.01323.x</pub-id></citation></ref><ref id="B5"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ng</surname><given-names>EKO</given-names></name><name><surname>Hui</surname><given-names>DS</given-names></name><name><surname>Chan</surname><given-names>KCA</given-names></name><name><surname>Hung</surname><given-names>EC</given-names></name><name><surname>Chiu</surname><given-names>RWK</given-names></name><name><surname>Lee</surname><given-names>N</given-names></name><name><surname>Wu</surname><given-names>A</given-names></name><name><surname>Chim</surname><given-names>SSC</given-names></name><name><surname>Tong</surname><given-names>YK</given-names></name><name><surname>Sung</surname><given-names>JJ</given-names></name><name><surname>Tam</surname><given-names>JS</given-names></name><name><surname>Lo</surname><given-names>YMD</given-names></name></person-group><article-title>Quantitative analysis and prognostic implication of SARS coronavirus RNA in the plasma and serum of patients with severe acute respiratory syndrome</article-title><source>Clin Chem</source><year>2003</year><volume>49</volume><fpage>1976</fpage><lpage>1980</lpage><pub-id pub-id-type="pmid">14633867</pub-id><pub-id pub-id-type="doi">10.1373/clinchem.2003.024125</pub-id></citation></ref><ref id="B6"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chim</surname><given-names>SSC</given-names></name><name><surname>Tsui</surname><given-names>SK</given-names></name><name><surname>Chan</surname><given-names>KCA</given-names></name><name><surname>Au</surname><given-names>TC</given-names></name><name><surname>Hung</surname><given-names>EC</given-names></name><name><surname>Tong</surname><given-names>YK</given-names></name><name><surname>Chiu</surname><given-names>RWK</given-names></name><name><surname>Ng</surname><given-names>EK</given-names></name><name><surname>Chan</surname><given-names>PKS</given-names></name><name><surname>Chu</surname><given-names>CM</given-names></name><name><surname>Sung</surname><given-names>JJ</given-names></name><name><surname>Tam</surname><given-names>JS</given-names></name><name><surname>Fung</surname><given-names>KP</given-names></name><name><surname>Waye</surname><given-names>MM</given-names></name><name><surname>Lee</surname><given-names>CY</given-names></name><name><surname>Yuen</surname><given-names>KY</given-names></name><name><surname>Lo</surname><given-names>YMD</given-names></name></person-group><article-title>Genomic characterisation of the severe acute respiratory syndrome coronavirus of Amoy Gardens outbreak in Hong Kong</article-title><source>Lancet</source><year>2003</year><volume>362</volume><fpage>1807</fpage><lpage>1808</lpage><pub-id pub-id-type="pmid">14654320</pub-id><pub-id pub-id-type="doi">10.1016/S0140-6736(03)14901-X</pub-id></citation></ref><ref id="B7"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ng</surname><given-names>MH</given-names></name><name><surname>Lau</surname><given-names>KM</given-names></name><name><surname>Li</surname><given-names>L</given-names></name><name><surname>Cheng</surname><given-names>SH</given-names></name><name><surname>Chan</surname><given-names>WY</given-names></name><name><surname>Hui</surname><given-names>PK</given-names></name><name><surname>Zee</surname><given-names>B</given-names></name><name><surname>Leung</surname><given-names>CB</given-names></name><name><surname>Sung</surname><given-names>JJ</given-names></name></person-group><article-title>Association of human-leukocyte-antigen class I (B*0703) and class II (DRB1*0301) genotypes with susceptibility and resistance to the development of severe acute respiratory syndrome</article-title><source>J Infect Dis</source><year>2004</year><volume>190</volume><fpage>515</fpage><lpage>8. Epub 2004 Jul 07.</lpage><pub-id pub-id-type="pmid">15243926</pub-id><pub-id pub-id-type="doi">10.1086/421523</pub-id></citation></ref><ref id="B8"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname><given-names>M</given-names></name><name><surname>Tseng</surname><given-names>HK</given-names></name><name><surname>Trejaut</surname><given-names>JA</given-names></name><name><surname>Lee</surname><given-names>HL</given-names></name><name><surname>Loo</surname><given-names>JH</given-names></name><name><surname>Chu</surname><given-names>CC</given-names></name><name><surname>Chen</surname><given-names>PJ</given-names></name><name><surname>Su</surname><given-names>YW</given-names></name><name><surname>Lim</surname><given-names>KH</given-names></name><name><surname>Tsai</surname><given-names>ZU</given-names></name><name><surname>Lin</surname><given-names>RY</given-names></name><name><surname>Lin</surname><given-names>RS</given-names></name><name><surname>Huang</surname><given-names>CH</given-names></name></person-group><article-title>Association of HLA class I with severe acute respiratory syndrome coronavirus infection</article-title><source>BMC Med Genet</source><year>2003</year><volume>4</volume><fpage>9</fpage><pub-id pub-id-type="pmid">12969506</pub-id><pub-id pub-id-type="doi">10.1186/1471-2350-4-9</pub-id></citation></ref><ref id="B9"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chiu</surname><given-names>RWK</given-names></name><name><surname>Tang</surname><given-names>NL</given-names></name><name><surname>Hui</surname><given-names>DS</given-names></name><name><surname>Chung</surname><given-names>GT</given-names></name><name><surname>Chim</surname><given-names>SSC</given-names></name><name><surname>Chan</surname><given-names>KCA</given-names></name><name><surname>Sung</surname><given-names>YM</given-names></name><name><surname>Chan</surname><given-names>LY</given-names></name><name><surname>Tong</surname><given-names>YK</given-names></name><name><surname>Lee</surname><given-names>WS</given-names></name><name><surname>Chan</surname><given-names>PK</given-names></name><name><surname>Lo</surname><given-names>YMD</given-names></name></person-group><article-title>ACE2 gene polymorphisms do not affect outcome of severe acute respiratory syndrome</article-title><source>Clin Chem</source><year>2004</year><volume>50</volume><fpage>1683</fpage><lpage>1686</lpage><pub-id pub-id-type="pmid">15331509</pub-id><pub-id pub-id-type="doi">10.1373/clinchem.2004.035436</pub-id></citation></ref><ref id="B10"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Itoyama</surname><given-names>S</given-names></name><name><surname>Keicho</surname><given-names>N</given-names></name><name><surname>Quy</surname><given-names>T</given-names></name><name><surname>Phi</surname><given-names>NC</given-names></name><name><surname>Long</surname><given-names>HT</given-names></name><name><surname>Ha le</surname><given-names>D</given-names></name><name><surname>Ban</surname><given-names>VV</given-names></name><name><surname>Ohashi</surname><given-names>J</given-names></name><name><surname>Hijikata</surname><given-names>M</given-names></name><name><surname>Matsushita</surname><given-names>I</given-names></name><name><surname>Kawana</surname><given-names>A</given-names></name><name><surname>Yanai</surname><given-names>H</given-names></name><name><surname>Kirikae</surname><given-names>T</given-names></name><name><surname>Kuratsuji</surname><given-names>T</given-names></name><name><surname>Sasazuki</surname><given-names>T</given-names></name></person-group><article-title>ACE1 polymorphism and progression of SARS</article-title><source>Biochem Biophys Res Commun</source><year>2004</year><volume>323</volume><fpage>1124</fpage><lpage>1129</lpage><pub-id pub-id-type="pmid">15381116</pub-id><pub-id pub-id-type="doi">10.1016/j.bbrc.2004.08.208</pub-id></citation></ref><ref id="B11"><citation citation-type="other"><person-group person-group-type="author"><collab>WHO</collab></person-group><article-title>Case Definitions for Surveillance of Severe Acute Respiratory Syndrome (SARS)</article-title><source>http://wwwwhoint/csr/sars/casedefinition/en/</source><year>2004</year></citation></ref><ref id="B12"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bernard</surname><given-names>GR</given-names></name><name><surname>Artigas</surname><given-names>A</given-names></name><name><surname>Brigham</surname><given-names>KL</given-names></name><name><surname>Carlet</surname><given-names>J</given-names></name><name><surname>Falke</surname><given-names>K</given-names></name><name><surname>Hudson</surname><given-names>L</given-names></name><name><surname>Lamy</surname><given-names>M</given-names></name><name><surname>Legall</surname><given-names>JR</given-names></name><name><surname>Morris</surname><given-names>A</given-names></name><name><surname>Spragg</surname><given-names>R</given-names></name></person-group><article-title>The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination</article-title><source>Am J Respir Crit Care Med</source><year>1994</year><volume>149</volume><fpage>818</fpage><lpage>824</lpage><pub-id pub-id-type="pmid">7509706</pub-id></citation></ref><ref id="B13"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Marshall</surname><given-names>RP</given-names></name><name><surname>Webb</surname><given-names>S</given-names></name><name><surname>Bellingan</surname><given-names>GJ</given-names></name><name><surname>Montgomery</surname><given-names>HE</given-names></name><name><surname>Chaudhari</surname><given-names>B</given-names></name><name><surname>McAnulty</surname><given-names>RJ</given-names></name><name><surname>Humphries</surname><given-names>SE</given-names></name><name><surname>Hill</surname><given-names>MR</given-names></name><name><surname>Laurent</surname><given-names>GJ</given-names></name></person-group><article-title>Angiotensin converting enzyme insertion/deletion polymorphism is associated with susceptibility and outcome in acute respiratory distress syndrome</article-title><source>Am J Respir Crit Care Med</source><year>2002</year><volume>166</volume><fpage>646</fpage><lpage>650</lpage><pub-id pub-id-type="pmid">12204859</pub-id><pub-id pub-id-type="doi">10.1164/rccm.2108086</pub-id></citation></ref><ref id="B14"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname><given-names>B</given-names></name><name><surname>Moochhala</surname><given-names>SM</given-names></name><name><surname>Tham</surname><given-names>S</given-names></name><name><surname>Lu</surname><given-names>J</given-names></name><name><surname>Chia</surname><given-names>M</given-names></name><name><surname>Byrne</surname><given-names>C</given-names></name><name><surname>Hu</surname><given-names>Q</given-names></name><name><surname>Lee</surname><given-names>LK</given-names></name></person-group><article-title>Relationship between angiotensin-converting enzyme ID polymorphism and VO(2max) of Chinese males</article-title><source>Life Sci</source><year>2003</year><volume>73</volume><fpage>2625</fpage><lpage>2630</lpage><pub-id pub-id-type="pmid">12967686</pub-id><pub-id pub-id-type="doi">10.1016/S0024-3205(03)00608-8</pub-id></citation></ref><ref id="B15"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Costerousse</surname><given-names>O</given-names></name><name><surname>Allegrini</surname><given-names>J</given-names></name><name><surname>Lopez</surname><given-names>M</given-names></name><name><surname>Alhenc-Gelas</surname><given-names>F</given-names></name></person-group><article-title>Angiotensin I-converting enzyme in human circulating mononuclear cells: genetic polymorphism of expression in T-lymphocytes</article-title><source>Biochem J</source><year>1993</year><volume>290</volume><fpage>33</fpage><lpage>40</lpage><pub-id pub-id-type="pmid">8382480</pub-id></citation></ref><ref id="B16"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Koh</surname><given-names>WP</given-names></name><name><surname>Yuan</surname><given-names>JM</given-names></name><name><surname>Sun</surname><given-names>CL</given-names></name><name><surname>van den Berg</surname><given-names>D</given-names></name><name><surname>Seow</surname><given-names>A</given-names></name><name><surname>Lee</surname><given-names>HP</given-names></name><name><surname>Yu</surname><given-names>MC</given-names></name></person-group><article-title>Angiotensin I-converting enzyme (ACE) gene polymorphism and breast cancer risk among Chinese women in Singapore</article-title><source>Cancer Res</source><year>2003</year><volume>63</volume><fpage>573</fpage><lpage>578</lpage><pub-id pub-id-type="pmid">12566298</pub-id></citation></ref><ref id="B17"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tse</surname><given-names>GM</given-names></name><name><surname>To</surname><given-names>KF</given-names></name><name><surname>Chan</surname><given-names>PK</given-names></name><name><surname>Lo</surname><given-names>AW</given-names></name><name><surname>Ng</surname><given-names>KC</given-names></name><name><surname>Wu</surname><given-names>A</given-names></name><name><surname>Lee</surname><given-names>N</given-names></name><name><surname>Wong</surname><given-names>HC</given-names></name><name><surname>Mak</surname><given-names>SM</given-names></name><name><surname>Chan</surname><given-names>KF</given-names></name><name><surname>Hui</surname><given-names>DS</given-names></name><name><surname>Sung</surname><given-names>JJ</given-names></name><name><surname>Ng</surname><given-names>HK</given-names></name></person-group><article-title>Pulmonary pathological features in coronavirus associated severe acute respiratory syndrome (SARS)</article-title><source>J Clin Pathol</source><year>2004</year><volume>57</volume><fpage>260</fpage><lpage>265</lpage><pub-id pub-id-type="pmid">14990596</pub-id><pub-id pub-id-type="doi">10.1136/jcp.2003.013276</pub-id></citation></ref><ref id="B18"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Colhoun</surname><given-names>HM</given-names></name><name><surname>McKeigue</surname><given-names>PM</given-names></name><name><surname>Davey Smith</surname><given-names>G</given-names></name></person-group><article-title>Problems of reporting genetic associations with complex outcomes</article-title><source>Lancet</source><year>2003</year><volume>361</volume><fpage>865</fpage><lpage>872</lpage><pub-id pub-id-type="pmid">12642066</pub-id><pub-id pub-id-type="doi">10.1016/S0140-6736(03)12715-8</pub-id></citation></ref><ref id="B19"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Daly</surname><given-names>AK</given-names></name><name><surname>Day</surname><given-names>CP</given-names></name></person-group><article-title>Candidate gene case-control association studies: advantages and potential pitfalls</article-title><source>Br J Clin Pharmacol</source><year>2001</year><volume>52</volume><fpage>489</fpage><lpage>499</lpage><pub-id pub-id-type="pmid">11736857</pub-id><pub-id pub-id-type="doi">10.1046/j.0306-5251.2001.01510.x</pub-id></citation></ref></ref-list></back></article> 